In a previous study of 62 lung cancer patients with minor EGFR mutations, Wu et al(17) observed a favorable response to EGFR-TKIs in 28 patients with point mutations on G719 and L861 and a poor response in 34 patients with different mutations. The gene discussed is EGFR; the disease is lung cancer.